Table 1 Characteristics of test cohort
From: MIR-708 promotes phagocytosis to eradicate T-ALL cells by targeting CD47
Type of sample | Characteristics | Median (range) | No.(%) |
|---|---|---|---|
T-ALL (N = 31) | Age at diagnosis | 8(1-13) | |
Sex | |||
Male | 26 (83.9) | ||
Female | 5 (16.1) | ||
WBC, × 109/L | 174.8 (2.75-632.47) | ||
Less than 20 | 5 (16.1) | ||
20 or higher | 23 (74.1) | ||
N/A | 3 (9.8) | ||
FAB | |||
L1 | 3 (9.7) | ||
L2 | 19 (61.3) | ||
L3 | 4 (12.9) | ||
N/A | 5 (16.1) | ||
Risk group | |||
HR | 17 (54.8) | ||
MR | 9 (29.1) | ||
SR | 0 | ||
N/A | 5 (16.1) | ||
Prednisone response | |||
Good respond | 10 (32.2) | ||
Poor respond | 16 (51.6) | ||
N/A | 5 (16.1) | ||
Genetic mutation | |||
MLL rearrangement | 5(16.1) | ||
SIL-TAL1 | 1(3) | ||
BCR-ABL1 | 0 | ||
N/A | 25(80.9) |